🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Talabostat may stop the growth of tumor cells by blocking some o...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2005-12
Trial ID
NCT00303940
Treatments Being Tested
This phase II trial studies the side effects of talabostat and pembrolizuma...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-03-19
Trial ID
NCT04171219
Treatments Being Tested
The effects of a nasal high-flow (NHF) therapy in patients with chronic obs...
Status
Completed
Location
Helios Klinik Ambrock
Start Date
2014-04
Trial ID
NCT02083120
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of talabos...
Status
Completed
Location
University of Arkansas for Medical Science
Start Date
TBD
Trial ID
NCT00086203
Treatments Being Tested
The purpose of this study is to determine the antitumor activity (response ...
Status
Completed
Location
Cancer Center of Florida
Start Date
TBD
Trial ID
NCT00080080
Treatments Being Tested
Single-arm, open label study to determine the 18 week progression-free surv...
Status
Active Not Recruiting
Location
Georgetown Lombardi Comprehensive Cancer Center
Start Date
2023-08-16
Trial ID
NCT05558982
Treatments Being Tested
This Phase 3 study will compare the efficacy of talabostat plus docetaxel t...
Status
Terminated
Location
Marshall Schreeder, MD
Start Date
2006-01
Trial ID
NCT00243204
Treatments Being Tested
The purpose of this study is to assess the 6-month survival rate and safety...
Status
Terminated
Location
Northwest Alabama Cancer Center, PC
Start Date
TBD
Trial ID
NCT00116389
Treatments Being Tested
An open-label, multicenter, Phase 1b/2 study to identify the recommended Ph...
Status
Completed
Location
University of California San Francisco (UCSF)
Start Date
2019-02-12
Trial ID
NCT03910660
Treatments Being Tested
The goal of this research study is to find the safest and most effective do...
Status
Recruiting
Location
Dana Farber Cancer Institute
Start Date
2023-02-02
Trial ID
NCT05703542
Treatments Being Tested